The top drug companies are buying up more and more generic drugs.
As of March 15, there were 3,859 generic drugs in use in the United States, according to data from the US Food and Drug Administration (FDA).
That’s up from 1,839 in 2014, and is nearly 10 percent higher than the number in 2012.
The total number of generic drugs is up about 2 percent over the past two years, and almost 6 percent since 2009.
The top five drug companies in the world are Pfizer, AstraZeneca, Sanofi, Johnson & Johnson, and Bristol-Myers Squibb.
The five largest generic drug companies by revenue, Pfizer and Astra, together hold about 85 percent of the market.
In the United Kingdom, there are four top five generic drug firms, Asta, Pfiser, Bristol- Myers Squab, and Pfizer.
In Italy, there is only one top five.
The U.S. also has five.
These figures come from the FDA’s database of generic drug sales.
The data is a compendium of sales data from pharmaceuticals, hospitals, drugmakers, and distributors, and includes all drugs that are available in the U.